메뉴 건너뛰기




Volumn 20, Issue 5, 2009, Pages 371-373

Perioperative haemostatic management of Glanzmann thrombasthenia for abdominal surgery

Author keywords

Anaesthesia; Haemorrhage; Hysterectomy; Recombinant activated factor VII

Indexed keywords

BLOOD CLOTTING FACTOR 13 CONCENTRATE; FIBRINOGEN; HAEMOCOMPLETTAN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

EID: 68149131598     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32832b280e     Document Type: Article
Times cited : (10)

References (14)
  • 1
    • 34247896877 scopus 로고    scopus 로고
    • Glanzmann thrombasthenia
    • Nurden AT. Glanzmann thrombasthenia. Orphanet J Rare Dis 2006; 1:10.
    • (2006) Orphanet J Rare Dis , vol.1 , pp. 10
    • Nurden, A.T.1
  • 2
    • 28444438137 scopus 로고    scopus 로고
    • Coronary artery bypass grafting in a patient with Glanzmann's thrombasthenia
    • Ryckman JG, Hall S, Serra J. Coronary artery bypass grafting in a patient with Glanzmann's thrombasthenia. J Card Surg 2005; 20:555-556.
    • (2005) J Card Surg , vol.20 , pp. 555-556
    • Ryckman, J.G.1    Hall, S.2    Serra, J.3
  • 3
    • 31144465054 scopus 로고    scopus 로고
    • Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia
    • Yilmaz BT, Alioglu B, Ozyurek E, Akay HT, Mercan S, Ozbek N. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia. Pediatr Cardiol 2005; 26:843-845.
    • (2005) Pediatr Cardiol , vol.26 , pp. 843-845
    • Yilmaz, B.T.1    Alioglu, B.2    Ozyurek, E.3    Akay, H.T.4    Mercan, S.5    Ozbek, N.6
  • 4
    • 10444278042 scopus 로고    scopus 로고
    • Recombinant factor VIIa in a patient with Glanzmann's thrombasthenia undergoing gynecological surgery: Open issues in light of successful treatment
    • Coppola A, Tufano A, Cimino E, Agangi A, Maruotti GM, Martinelli P, Di Minno G. Recombinant factor VIIa in a patient with Glanzmann's thrombasthenia undergoing gynecological surgery: open issues in light of successful treatment. Thromb Haemost 2004; 92:1450-1452.
    • (2004) Thromb Haemost , vol.92 , pp. 1450-1452
    • Coppola, A.1    Tufano, A.2    Cimino, E.3    Agangi, A.4    Maruotti, G.M.5    Martinelli, P.6    Di Minno, G.7
  • 5
    • 4544229639 scopus 로고    scopus 로고
    • Recombinant factor VIIa: Review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors
    • Abshire T, Kenet G. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors. J Thromb Haemost 2004; 2:899-909.
    • (2004) J Thromb Haemost , vol.2 , pp. 899-909
    • Abshire, T.1    Kenet, G.2
  • 6
    • 19944431107 scopus 로고    scopus 로고
    • Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: Results of an international survey
    • Poon MC, D'Oiron R, Von Depka M, Khair K, Negrier C, Karafoulidou A, et al. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. J Thromb Haemost 2004; 2:1096-1103.
    • (2004) J Thromb Haemost , vol.2 , pp. 1096-1103
    • Poon, M.C.1    D'Oiron, R.2    Von Depka, M.3    Khair, K.4    Negrier, C.5    Karafoulidou, A.6
  • 7
    • 33749565827 scopus 로고    scopus 로고
    • Use of rFVIIa in 4 children with Glanzmann thrombasthenia
    • Valentino LA. Use of rFVIIa in 4 children with Glanzmann thrombasthenia. J Pediatr Hematol Oncol 2006; 28:653-658.
    • (2006) J Pediatr Hematol Oncol , vol.28 , pp. 653-658
    • Valentino, L.A.1
  • 8
    • 0026924126 scopus 로고
    • Transfusion problems in patients with Glanzmann's thrombasthenia
    • Laursen B, Jacobsen SE, Taaning E, Grunnet N. Transfusion problems in patients with Glanzmann's thrombasthenia. Eur J Haematol 1992; 49:143-144.
    • (1992) Eur J Haematol , vol.49 , pp. 143-144
    • Laursen, B.1    Jacobsen, S.E.2    Taaning, E.3    Grunnet, N.4
  • 9
    • 33749355621 scopus 로고    scopus 로고
    • A case of Glanzmann's thrombasthenia successfully treated with recombinant factor VIIa during a surgical procedure: Observations on the monitoring and the mechanism of action of this drug
    • Dargaud Y, Bordet JC, Trzeciak MC, Vinciguerra C, Negrier C. A case of Glanzmann's thrombasthenia successfully treated with recombinant factor VIIa during a surgical procedure: observations on the monitoring and the mechanism of action of this drug. Haematologica 2006; 91:58-61.
    • (2006) Haematologica , vol.91 , pp. 58-61
    • Dargaud, Y.1    Bordet, J.C.2    Trzeciak, M.C.3    Vinciguerra, C.4    Negrier, C.5
  • 10
    • 1442308083 scopus 로고    scopus 로고
    • Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factorindependent fibrin generation
    • Lisman T, Adelmeijer J, Heijnen HF, de Groot PG. Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factorindependent fibrin generation. Blood 2004; 103:1720-1727.
    • (2004) Blood , vol.103 , pp. 1720-1727
    • Lisman, T.1    Adelmeijer, J.2    Heijnen, H.F.3    de Groot, P.G.4
  • 11
    • 0036257717 scopus 로고    scopus 로고
    • Peripartum management of a patient with Glanzmann's thrombasthenia using thrombelastograph
    • Monte S, Lyons G. Peripartum management of a patient with Glanzmann's thrombasthenia using thrombelastograph. Br J Anaesth 2002; 88:734-738.
    • (2002) Br J Anaesth , vol.88 , pp. 734-738
    • Monte, S.1    Lyons, G.2
  • 12
    • 0345700346 scopus 로고    scopus 로고
    • Devecioglu O, Unuvar A, Anak S, Bilge I, Ander H, Ziylan O. Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions. Turk J Pediatr 2003; 45:64-66.
    • Devecioglu O, Unuvar A, Anak S, Bilge I, Ander H, Ziylan O. Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions. Turk J Pediatr 2003; 45:64-66.
  • 13
    • 0037298416 scopus 로고    scopus 로고
    • Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia
    • Chuansumrit A, Suwannuraks M, Sri-Udomporn N, Pongtanakul B, Worapongpaiboon S. Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia. Blood Coagul Fibrinolysis 2003; 14:187-190.
    • (2003) Blood Coagul Fibrinolysis , vol.14 , pp. 187-190
    • Chuansumrit, A.1    Suwannuraks, M.2    Sri-Udomporn, N.3    Pongtanakul, B.4    Worapongpaiboon, S.5
  • 14
    • 37749016880 scopus 로고    scopus 로고
    • Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram
    • Lak M, Scharling B, Blemings A, Sharifian R, Maleki Z, Daraee A, et al. Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram. Haemophilia 2008; 14:103-110.
    • (2008) Haemophilia , vol.14 , pp. 103-110
    • Lak, M.1    Scharling, B.2    Blemings, A.3    Sharifian, R.4    Maleki, Z.5    Daraee, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.